Publication | Closed Access

Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction

HypertensionVascular Endothelial DysfunctionCardiovascular DiseaseOral Multi-kinases InhibitorMedicineAntihypertensive TherapyPhysiologyVascular PharmacologyCardiovascular PharmacologyEndothelial DysfunctionPotential RoleVascular BiologyPharmacotherapyPharmacologyAtherosclerosisEndocrine Hypertension